Kawase, K., Yoshida, K., Hara, K., Hidaka, S., & Takeyama, H. (2023). Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer. Clinical Medicine Insights, 4(2), 378–386. https://doi.org/10.52845/CMI/2023-4-2-1